Boston Scientific Corporation (BSX): Among the Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private health insurance is the two leading causes of this increase.
The impact of tariffs on this continuing trend has become a significant bone of contention in the healthcare industry as more and more US corporations turn to China for agreements on the next breakthrough chemical, whether in the areas of obesity or cancer. Carlo Rizzuto, managing director of Versant Ventures, spoke on CNBC's "Fast Money" on February 7 about the impact of tariffs on healthcare. Rizzuto says that tariffs may impact the sector in two ways. Products made in China and sold in the US or other countries would be the first. The industry would need to watch how the tariffs are used in the market to comprehend how they would impact such trade operations.
Second, and more precisely, the US healthcare industry relies heavily on China as a basis for contract production and research. Consequently, anything that raises that price is probably going to make the market more difficult. Cost hikes won't help the healthcare industry's management, which is already under pressure from investors.
Speaking on China's enormous impact in the pharmaceutical and healthcare sectors, Rizzuto said that the vast majority of healthcare companies use a Chinese CRO or manufacturing partner in some capacity during the research and development phase. As a result, it significantly affects how the nation's biotech and pharmaceutical industries function. This trend is rather common in businesses of all sizes.
In other words, the lack of infrastructure to facilitate the transfer prevents healthcare corporations from reshoring all of their externalized R&D and production to the United States. Therefore, it is hard to imagine how such a large-scale reshoring might occur. The amount of tariffs imposed can be used to determine the expenses of achieving this objective linearly.
According to McKinsey, healthcare EBITDA will rise from a starting point of $676 billion in 2023 to $987 billion in 2028 at a 7% CAGR. Recovery from post-pandemic lows is anticipated to spur progress in several areas, even though development is anticipated to be faster in some (such as specialized pharmacy and HST). Software platforms are essential to the healthcare ecosystem because they let payers and providers operate more effectively in a complex environment.
By automating procedures, fostering data connectivity, and producing actionable insights, technological innovation (such as generative AI and machine learning) keeps providing opportunities for stakeholders from all industries. McKinsey predicts that increased utilization and pipeline expansion (as in cancer) will result in a considerable increase in specialty pharmacy income. Specialty pharmacy profit pools are continuing to grow as a result of the rise in the use of specialty medications.
For this article, we began by screening the top holdings of the iShares U.S. Healthcare ETF (IYH) to focus on prominent companies within the U.S. healthcare sector. From this list, we selected the top 10 holdings based on their weight in the ETF portfolio. We then ranked these stocks according to the number of hedge funds holding positions in each company as of Q4 2024, based on data from Insider Monkey's hedge fund tracking database.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A surgeon examining a patient's brain in an operating room, paramedics nearby.
Number of Hedge Fund Holders: 96
The fifth stock on our list of the best healthcare stocks is Boston Scientific Corporation (NYSE:BSX). It is a Massachusetts-based company that specializes in developing, manufacturing, and distributing medical devices for interventional procedures worldwide. It is divided into two sections: Cardiovascular and MedSurg. Citing the company's impressive fourth-quarter earnings, Canaccord Genuity raised the price objective from $101 to $117 on February 6 and kept its Buy rating on the shares.
In the fourth quarter of 2024, Boston Scientific Corporation (NYSE:BSX) recorded net sales of over $4.6 billion, a 22.4% increase over the same time the previous year. Compared to $504 million, or $0.34 per share, in the previous year, GAAP net income attributable to common stockholders increased to $566 million, or $0.38 per share. Adjusted EPS for Q4 increased from $0.55 to $0.7. Net sales for 2024 as a whole came to $16.75 billion, representing a 17.6% increase over the previous year.
Boston Scientific Corporation (NYSE:BSX) announced on March 3 that it has reached a final deal to buy the privately held medical device startup SoniVie Ltd. The TIVUS Intravascular Ultrasound System, an experimental device created by SoniVie, is intended to treat hypertension disorders by targeting the nerves that surround blood vessels.
Overall BSX ranks 5th among the innovative healthcare stocks to watch in 2025. While we acknowledge the potential of BSX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BSX but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds' investor letters by entering your email address below.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
23 minutes ago
- Yahoo
Tencent Music shares rise after acquiring podcast giant Ximalaya
-- Tencent Music Entertainment Group (NYSE:TME) shares rose 5.4% on Tuesday following news that the company will acquire Chinese podcast platform Ximalaya in a $2.4 billion cash-and-stock transaction. The deal, aimed at positioning Tencent Music as a dominant force in China's online audio sector, mirrors a broader industry shift toward diversified audio services, in line with global peers such as Spotify (NYSE:SPOT). According to a June 10 filing with the Securities and Exchange Commission, Tencent Music signed a definitive Agreement and Plan of Merger to acquire Ximalaya, pending regulatory approvals and customary closing conditions. Upon closing, Ximalaya will become a wholly owned subsidiary of Tencent Music, significantly expanding its footprint in China's rapidly growing podcast market. Ximalaya, one of the country's most popular audio platforms, boasts 303 million monthly users and serves as a major destination for podcasts, audiobooks, and livestream content. The merger, if finalized, would instantly elevate Tencent Music's user base and deepen its content offerings beyond music. The transaction includes $1.26 billion in cash and an equity component comprising Tencent Music Class A ordinary shares, representing up to 5.5686% of the Company's total issued and outstanding shares before closing. A portion of those shares, 0.37% of the total, will be distributed to Ximalaya founder shareholders post-closing, subject to conditions outlined in the agreement. Ximalaya will also undergo a restructuring of certain existing business units before the deal is completed, though full details of that process were not disclosed. Tencent Music emphasized that the restructuring and integration would support long-term synergistic value creation. The acquisition reflects Tencent Music's ongoing effort to evolve from a music-streaming platform to a broader digital audio enterprise. As competition rises and subscription growth slows in traditional streaming, players are increasingly looking to podcasting and user-generated audio to deepen engagement and create new monetization channels. Related articles Tencent Music shares rise after acquiring podcast giant Ximalaya Citi adds Qorvo and Skyworks Solutions to 90-day upside catalyst watch OpenAI to use Google cloud service alongside Microsoft Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
QCOM Gains Traction in Automotive: Will It Deliver Sustainable Growth?
Qualcomm Incorporated QCOM has been witnessing solid momentum in the automotive segment over the past few quarters. During the second quarter of 2025, the company reported staggering 59% year-over-year growth in this segment. It boasts a worldwide client base that includes leading automakers and technology companies like General Motors, BMW, Mercedes-Benz, Renault Group, Royal Enfield, Volvo, Google and more. Over the past few years, Qualcomm has taken an approach of continuous innovation with strategic acquisitions to expand into the automotive the acquisition of Veneer, Inc., the company has steadily gained a strong foothold in the emerging market of driver-assistance technology. The Arriver business of Veoneer operates the dedicated software unit focused on sensor perception and drive policy, including a full stack of features and functions. With this buyout, Qualcomm has integrated Arriver's Computer Vision, Drive Policy and Driver Assistance assets into its ADAS (Advanced Driver Assistance System) portfolio. It has allowed QCOM to deliver an open and competitive platform for automakers to better compete with rivals within the self-driving vehicle market. The company recently acquired Autotalks, an industry leader in direct vehicle-to-everything communication technology. Integration of Autotalks' robust portfolio of automotive-qualified global V2X solutions will facilitate the development of leading-edge, reliable solutions to enhance road safety and optimize traffic demand for the company's Snapdragon Digital Chassis product portfolio, which includes telematics and connectivity platforms, digital cockpit and C-V2X solutions, is expected to drive growth in automotive in the near term. In the second quarter, Qualcomm secured 30 new designs, including five ADAS programs and designs from Chinese automakers such as Nio, Zeekr, Great Wall, Dongfeng and more. Per our estimate, the company is expected to generate $3.7 billion in revenues from the automotive segment, indicating 27.3% year-over-year growth. In the automotive segment, the company faces competition from the NVIDIA Corporation NVDA and Intel Corporation INTC. NVIDIA DRIVE solutions include a comprehensive stack of hardware and software tools designed to support autonomous vehicles. It is also swiftly working on V2X technology, specifically in AI-driven connectivity for autonomous vehicles. With a vast client base that includes Mercedes-Benz, Li Auto, General Motors, Toyota and several other prominent automakers, NVIDIA has gained solid market traction in the AI-driven autonomous driving Mobileye has rapidly expanded in the autonomous car technology market. Mobileye's technologies related to cameras, in-car networking, sensor chips, roadway mapping, cloud software, machine learning and data management are gaining popularity among automakers. More than 70 million vehicles from BMW, Volkswagen, Ford and Nissan use Intel's Mobileye for driver assistance. However, with the integration of advanced V2X and a broader portfolio of digital cockpit, infotainment and connectivity, Qualcomm is expected to maintain its competitive edge in the automotive vertical. QCOM shares have declined 25.5% over the past year against the industry's growth of 18.1%. Image Source: Zacks Investment Research Going by the price/earnings ratio, the company's shares currently trade at 12.87 forward earnings, lower than 30.31 for the industry and the stock's mean of 17.79. It carries a Value Score of A. Image Source: Zacks Investment Research Earnings estimates for 2025 have decreased 0.17% to $11.8 per share over the past 60 days, while the same for 2026 have decreased 3.18% to $12.19. Image Source: Zacks Investment Research Qualcomm stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intel Corporation (INTC) : Free Stock Analysis Report QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
China Extends Probe Into EU Pork Imports
China said Tuesday that it would extend a yearlong probe into pork imports from the European Union, as Beijing seeks to bolster ties with the 27-member bloc amid heightened trade tensions with the U.S. The Chinese Commerce Ministry decided to extend its antidumping investigation into EU pork products by six months to Dec. 16, citing the complexity of the case, according to an official notice. Think Twice Before You Click 'Unsubscribe' The Canned-Food Aisle Is Getting Squeezed by Rising Steel Tariffs The Best New Features Coming to Your iPhone, iPad and Mac (and What's Missing) FTC Seeks Information From Top Advertising Agencies as Part of Ad-Boycott Probe Judge Tosses Justin Baldoni's Lawsuits Against Blake Lively and New York Times The probe was launched last June in response to the EU's decision to slap antisubsidy levies on Chinese electric vehicles and was originally set to conclude later this month. Most of the EU's pork exports go to East Asia, in particular China, with Germany, Spain and France among the biggest producers, according to the European Commission. Tuesday's announcement is viewed as another goodwill gesture by Beijing, as Chinese leaders launch a global charm offensive to improve relations with major economic partners amid a trading fight with Washington. Back in April, Beijing extended a similar probe into brandy imports from the EU by three months to July and expanded Spanish pork exporters' access to the Chinese market through bilateral trade agreements. Earlier this month, Chinese Commerce Minister Wang Wentao talked with EU trade officials over a range of issues including Chinese EVs and export controls during a trip to France. In a statement after Wang's trip, the Chinese Commerce Ministry said negotiations with the EU on setting minimum prices for Chinese-made EVs have entered its final stages. Wang also said in his meetings with European counterparts that China will accelerate approvals of qualified rare-earth exports to Europe, adding that he hopes the EU can bolster exports of high-tech products to the country, according to the ministry. In retaliation against President Trump's 'Liberation Day' tariffs in April, China slapped new export controls on seven types of rare-earth minerals that are needed for a range of products including electronics, cars and advanced defense equipment. Such restrictions from the world's dominant rare-earth supplier have become a headache for global businesses, especially American and European automakers, many of which have warned of significant disruption in the global supply chain. Tuesday's extension also came as senior officials from China and the U.S. are meeting in London for their second round of talks with export controls taking the center stage. Write to Singapore Editors at singaporeeditors@ Alexander Brothers File $500 Million Defamation Suit Against The Real Deal Warner Discovery Splits Cable From Marquee Streaming, Studio Businesses Apple Unveils Array of New Software, but AI Comeback Remains Far Off Disney to Pay NBCUniversal Another $438.7 Million for Hulu Stake Businesses Are Bingeing on Crypto, Dialing Up the Market's Risks Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati